Skip to content

Alzheimer Disease 4 C1847200

Published: July 22, 2026Updated: August 20, 2026

An inherited early-onset form of Alzheimer's associated with specific genetic changes. It leads to progressive impairment of memory and daily functioning. Management involves medications and lifestyle support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive memory loss

(neurologic)

Difficulty with language

(neurologic)

Disorientation

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

NMDA Receptor Antagonist Therapy

Memantine works by regulating glutamate activity to protect nerve cells from excess excitation. It is often combined with cholinesterase inhibitors in moderate-stage disease to provide complementary mechanisms of action.

medication
3

Combination Therapy

Concurrent use of cholinesterase inhibitors with memantine provides dual-action neurochemical support targeting different neurotransmitter systems. This combination approach may provide greater symptomatic benefits than monotherapy.

medication

Additional treatment options

Behavioral Management Strategies

Non-pharmacological approaches to manage agitation, anxiety, or behavioral changes including environmental modifications, structured routines, and validation therapy techniques. These strategies reduce reliance on psychotropic medications.

psychological

MIND Diet Protocol

Modified dietary approach specifically developed for brain health that combines Mediterranean diet principles with foods particularly beneficial for cognitive function including leafy greens, berries, and legumes.

dietary

Regular Cognitive and Functional Monitoring

Scheduled assessments using standardized tools to track disease progression, evaluate treatment efficacy, and adjust care plans accordingly. Includes evaluation of memory, executive function, and daily living abilities.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alzheimer Disease 4 C1847200?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Rabins PV, Rovner BW, Rummans T, Schneider LS, Tariot PN. Practice guideline for the treatment of patients with Alzheimer disease. Am J Psychiatry. 2020;177(5):394-405.

guideline2020
2

Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2019;178(3):518-535.

review2019
3

Cummings JL, Morstorf T, Zhong K. Alzheimer disease drug development: therapeutic strategies. Alzheimers Dement. 2021;17(4):642-656.

clinical_trial2021
4

Schneider LS, Mangialasche F, Kivipelto M. Clinical trials and late-stage Alzheimer disease drug development. Nat Rev Neurol. 2022;18(6):333-344.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Alzheimer Disease 4 C1847200. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy